Microdosing Side Effects Nobody Talks About

Why the conversation around side effects stays shallow

, with "improved mood" and "improved focus" dominating the data. The researchers noted this could partly reflect a reporting bias: people who have good experiences tend to keep going and keep talking, while those who stop often go quiet.

This matters because the online conversation around microdosing skews heavily toward success stories. Reddit threads, podcast episodes, and even some published surveys tend to surface the positive. Meanwhile, the illegal or restricted status of psilocybin and LSD in many jurisdictions discourages people from reporting adverse experiences to healthcare providers or researchers. There is simply less data on what goes wrong.

Long-term controlled studies remain rare., suggesting expectation effects play a meaningful role. But the same study also highlighted that side effects, though generally mild, were real and consistent enough to warrant attention.

This article is not anti-microdosing. It is pro-honesty. If you are going to engage with this practice, you deserve a clear-eyed picture of what you might experience beyond the highlight reel.

The well-known physical side effects (briefly)

The physical side effects most commonly reported in surveys and anecdotal accounts include nausea, mild headache, jaw tension or teeth clenching, changes in appetite (both increased and decreased), and disrupted sleep. These are well-documented in community surveys and are acknowledged in most introductory microdosing resources, so we will not dwell on them here.

A few points worth noting: nausea tends to be more common with psilocybin than LSD and often relates to the mushroom material itself rather than the active compound. Disrupted sleep is frequently linked to dose timing. If you are experiencing persistent sleep issues, our guide on sleep and rest during a microdosing practice goes deeper.

Cardiac considerations also deserve mention. While sub-perceptual doses involve very small amounts, people with pre-existing cardiac conditions should understand the landscape. Our heart health and microdosing guide covers what the evidence currently does and does not tell us. If you have a heart condition, consult your healthcare provider before beginning or continuing any microdosing protocol.

Emotional amplification, not just emotional improvement

Here is something the popular narrative often misses: sub-perceptual doses do not appear to selectively amplify positive emotions. What many people report, once they track carefully, is that microdosing can amplify whatever emotional landscape is already present.

While average scores on measures of wellbeing did improve, the researchers also found increases in neuroticism for a subset of participants. Some people felt more emotionally reactive, not less. More open, yes, but also more raw.

In practice, this means that a dose day during a stressful week might not bring the clarity or calm you were hoping for. Instead, it might surface irritability you had been managing, sadness you had been avoiding, or emotional overwhelm that catches you off guard. Some microdosers report that the day after a dose can be particularly intense emotionally, even when the dose day itself felt unremarkable.

This is not necessarily a problem. Increased emotional access can be valuable, especially when paired with reflective practices like journaling or therapy. But it becomes a problem when people expect only uplift and interpret amplified difficult emotions as a sign that they are doing it wrong, rather than recognising it as a feature of how these substances interact with the nervous system.

When microdosing makes anxiety worse

This is one of the most commonly searched concerns, and for good reason. While some people report that microdosing reduces their anxiety, others find the opposite: their anxiety gets louder, especially in the first few weeks of a protocol.

One hypothesis relates to neuroplasticity. Psychedelics, even at sub-perceptual doses, appear to promote neural flexibility. A 2023 review in Neuroscience and Biobehavioral Reviews by Calder and Hasler suggested that increased plasticity without adequate psychological scaffolding (meaning: practices, frameworks, or support that help you process what surfaces) could temporarily destabilise emotional regulation. In simple terms, your brain may become more open to new patterns before it has let go of old ones, and the overlap can feel like heightened anxiety.

People with pre-existing anxiety conditions seem particularly susceptible. If your baseline involves a heightened threat-detection system, amplifying neural sensitivity may not initially feel therapeutic. It may feel like your anxiety has been turned up, not down.

Set, setting, and integration matter even at sub-perceptual levels. This is easy to forget because the effects are, by definition, subtle. But the context in which you microdose, what you do with the experience afterwards, and whether you have support systems in place all influence outcomes.

Cognitive fog and the focus paradox

Sharpened focus is one of the most frequently cited reasons people begin microdosing, particularly those exploring it alongside attention difficulties. (Our article on microdosing for ADHD covers the evidence landscape there.) But a meaningful number of microdosers report the opposite experience: brain fog, word-finding difficulty, a spacey or slightly dissociated feeling, and reduced ability to concentrate on demanding tasks.

The Polito and Stevenson (2021) study mentioned earlier found that while some participants reported improved focus, others experienced decreased cognitive performance, particularly on dose days. The difference may come down to individual sensitivity and dose calibration.

What feels sub-perceptual varies from person to person. Body weight, metabolism, individual receptor density, the specific substance, and even recent food intake all play a role. A dose that is genuinely sub-perceptual for one person may be mildly perceptual for another, and at that threshold, cognitive function can be impaired rather than enhanced. If you are experiencing fog rather than focus, the dose may simply be too high for your physiology. Our guide on what to do if effects feel too strong walks through adjustment strategies.

Timing also matters. Some people find that morning doses interfere with the structured cognitive work of the first half of their day, while an adjusted schedule aligns better with their needs. This is one reason comparing different protocols can be valuable: the schedule that works for someone else may not suit your cognitive rhythms.

Social and relational shifts

Some of the most underreported side effects of microdosing are relational. People describe becoming more sensitive to the emotional states of those around them, finding it harder to "perform" in social situations that previously felt routine, and experiencing a sudden, sometimes uncomfortable intolerance of certain relationships or environments.

In community reports, this often gets framed as growth: "I stopped tolerating toxic people." And sometimes it genuinely is. But it can also be destabilising, particularly when the relationships in question are with partners, close friends, or colleagues. Feeling like you can suddenly "see through" social dynamics you previously navigated with ease is not always empowering. It can be isolating.

Some microdosers also report changes in libido or intimacy dynamics. For some, increased emotional openness deepens connection. For others, heightened sensitivity makes physical intimacy feel overwhelming, or shifts in emotional processing create a temporary distance from partners who are not having the same experience.

None of this is inherently good or bad. But it is worth being honest about. If your relationships are shifting in ways that feel confusing or distressing, that is worth noting, reflecting on, and potentially discussing with someone you trust, whether a therapist, a close friend, or your partner.

Notice what's shifting. Afterglow's guided journaling helps you track relational and emotional changes alongside your protocol, so patterns become visible before they become problems.

Tolerance and diminishing returns

Psilocybin and LSD both act on serotonin 5-HT2A receptors, and these receptors downregulate (become less responsive) with repeated exposure. This is pharmacological tolerance, and it happens relatively quickly. Research on full doses shows significant tolerance developing within days of consecutive use, which is precisely why most microdosing protocols build in rest days.

The Fadiman protocol (one day on, two days off) and the Stamets stack (four days on, three days off) both account for this. But even with rest days, some microdosers report that after several weeks or months, the practice feels like it has "stopped working." The subtle shifts in mood, focus, or openness that were noticeable early on seem to fade.

This can trigger a common and risky impulse: increasing the dose. The logic seems straightforward. If the current amount is not producing effects, more might. But this moves away from the sub-perceptual principle entirely, introduces a different risk profile, and may not even address the actual issue.

It is also worth considering that tolerance can be partly psychological. The novelty of beginning a new practice creates its own heightened awareness. You notice things because you are looking for them. Over time, as microdosing becomes routine, that heightened attention fades. The practice may still be doing something; you may just have recalibrated to a new baseline. This is where consistent tracking becomes particularly valuable, because your journal entries from week one and week eight can tell a more objective story than your felt sense alone.

The existential and identity-level effects

This is perhaps the side effect that gets the least attention, and it can be the most unsettling. Some people who microdose report beginning to question fundamental aspects of their lives: their career, their relationship, their values, the way they spend their time. Not in a gentle, curious way, but in a way that feels like the ground shifting underfoot.

Through the lens of Acceptance and Commitment Therapy (ACT), which informs the educational framework within Afterglow, this makes a certain kind of sense. ACT describes psychological flexibility as the ability to be present, open to experience, and willing to act in alignment with your values, even when it is uncomfortable. Increased psychological flexibility can initially feel a lot like instability. If you have been maintaining a life that works on the surface but does not align with your deeper values, increased openness can make that gap painfully visible.

This is not the same as saying microdosing reveals your "true self" or "wakes you up." That framing is too neat. What seems to happen, based on community reports and the broader psychedelic literature, is that habitual thought patterns become slightly less rigid. For some people, that creates space for welcome insight. For others, it creates a disorienting period where previously stable aspects of identity feel uncertain.

Knowing when to pause or stop

One of the most important skills in any microdosing practice is knowing when to stop. Not permanently, necessarily, but at least to pause and reassess. There is a culture around microdosing that can make stopping feel like giving up, but the opposite is true. Recognising when the practice is not serving you is a sign of taking it seriously.

Red flags that suggest pausing include:

• Persistent anxiety that worsens over multiple cycles, not just a single difficult dose day but a clear upward trend.
• Sleep disruption that does not resolve on off days. If your rest days are not actually restful, something needs to change.
• Emotional distress that exceeds what feels manageable or that is interfering with work, relationships, or daily functioning.
• Cognitive impairment that persists beyond dose days, including sustained brain fog, confusion, or difficulty concentrating.
• Any sign of perceptual disturbance, paranoia, or psychotic symptoms. This is non-negotiable. Stop immediately and seek professional support.

Our complete contraindications guide covers the full spectrum of conditions and circumstances where microdosing may carry elevated risk. If you are taking medications, particularly SSRIs, MAOIs, or lithium, consult our guide on microdosing and SSRIs and speak with your prescribing healthcare provider before making any changes.

How tracking changes the picture

Side effects are easy to dismiss in real time. A difficult morning gets attributed to poor sleep. Increased irritability gets blamed on work stress. A foggy afternoon gets chalked up to not drinking enough water. Without consistent tracking, it is remarkably easy to misattribute side effects or to miss patterns entirely.

This is where honest, structured journaling becomes one of the most powerful tools in a microdosing practice. Not journaling that only captures breakthroughs and insights, but journaling that logs the difficult days with the same care. What did you feel on dose days versus off days? Did your mood shift in the hours after dosing, or the day after? Did your anxiety follow a pattern across weeks?

Afterglow's pattern recognition features are designed for exactly this: surfacing trends across time that are hard to see from inside a single day's experience. But the principle matters more than the tool. Whether you use an app, a spreadsheet, or a paper notebook, the practice of honest, regular logging transforms vague feelings into actionable data. Track what is hard. It matters as much as tracking what feels good.

Honest practice, better outcomes

Acknowledging side effects is not a failure of the practice. It is a sign of maturity within it. The microdosing community benefits every time someone shares an honest account of a difficult experience alongside the positive ones. That honesty helps newcomers set realistic expectations, helps researchers understand the full picture, and helps the practice itself evolve toward greater safety and nuance.

If you are experiencing side effects, you are not doing it wrong. You are doing something that interacts with your unique neurobiology, psychology, life circumstances, and expectations in ways that are not fully predictable. The appropriate response is not to push through, and it is not to panic. It is to pay attention, adjust thoughtfully, and seek support when needed.

Remember that the legal status of psilocybin, LSD, and other substances commonly used in microdosing varies significantly by jurisdiction. Check your local laws. And regardless of where you live, consult a qualified healthcare provider before beginning or continuing a microdosing practice, particularly if you have pre-existing mental health conditions or are taking any medication.

The goal is not a perfect practice. The goal is an honest one.

References